Wyden's Pharma Probe Could Build Case For Int'l Tax Reforms
By Dylan Moroses · October 24, 2024, 5:37 PM EDT
Senate Finance Committee Chairman Ron Wyden's investigation into the tax planning of major U.S. pharmaceutical companies could help fuel an effort to revamp U.S. international tax laws next year when Congress...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login